News Roundup: COVID-19 Oral Pills Authorized, Booster Effective
The Best of the Best: 2021 Pharmacy Award Winners
https://www.drugtopics.com/view/the-best-of-the-best-2021-pharmacy-award-winners
Year in Review: 2021 Top Legal News from Drug Topics®
https://www.drugtopics.com/view/year-in-review-2021-top-legal-news-from-drug-topics-
Year in Review: 2021 Top Technology News from Drug Topics®
https://www.drugtopics.com/view/year-in-review-2021-top-technology-news-from-drug-topics-
Year in Review: 2021 Top CBD News from Drug Topics®
https://www.drugtopics.com/view/year-in-review-2021-top-cbd-news-from-drug-topics-
Year in Review: 2021 Top Expert Interviews from Drug Topics®
https://www.drugtopics.com/view/year-in-review-2021-top-expert-interviews-from-drug-topics-
Year in Review: 2021 Top Pain Management News from Drug Topics®
https://www.drugtopics.com/view/year-in-review-2021-top-pain-management-news-from-drug-topics-
FDA Issues EUA for First Oral Antiviral Pill for COVID-19
https://www.drugtopics.com/view/fda-issues-eua-for-first-oral-antiviral-pill-for-covid-19
FDA Authorizes Merck and Ridgeback Biotherapeutics COVID-19 Oral Pill
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
